Somewhere inside Swedbank, a payments platform has been quietly processing transactions, managing loyalty programs, and running a healthcare payments gateway across Norway. It was good enough to keep running but not strategic enough to invest in aggressively. That tension, the limbo between 'working fine' and 'growing fast,' is where private equity sees opportunity.

Investment firm Mimir Group has acquired PayEx's specialized payments and loyalty platform and launched it as a new entity: Everspring Solutions. PayEx, a wholly owned subsidiary of Swedbank since 2017, keeps a significant minority stake. The deal gives the platform operational independence and growth capital while maintaining the banking relationship that gives it credibility in a market where trust matters.

Nelson Walden, formerly Director of Business Development for the Nordics and Baltics at Visa, starts as CEO on April 1. When a fintech carve-out hires from Visa rather than promoting internally, it's telling you something about its ambitions.

PayEx has operated as Swedbank's payments arm since the acquisition in 2017. It's a profitable, functioning business with an established customer base across Northern Europe. The platform handles digital gift cards, value codes, merchant services, and industry-specific financing solutions. None of this is glamorous. All of it generates revenue.

The problem with running a fintech platform inside a bank is resource allocation. Banks optimize for regulatory compliance and core banking operations. Payments innovation, loyalty programs, and vertical-specific financing don't compete well for budget against mortgage systems and KYC infrastructure.

Raymond Klavestad, CEO of PayEx Group, acknowledged this directly: "By establishing Everspring as an independent company, we create the right conditions to accelerate further growth." That's bank-speak for 'we couldn't give it the attention it deserved, so we found someone who will.'

Buried in the announcement is the most interesting asset: Medipay, a specialized healthcare payments gateway currently operational in Norway with plans to expand across the Nordics. Healthcare payments in the Nordics are a regulatory maze. Different countries, different reimbursement models, different patient billing rules. Building a payments gateway that navigates all of it is the kind of boring, hard problem that creates genuinely defensible businesses.

Norway's healthcare system relies heavily on co-payments and out-of-pocket expenses for certain services. The administrative overhead of managing these payments, reconciling with insurance, handling patient billing, is enormous. Medipay sits in the middle, handling the transaction layer so healthcare providers can focus on, well, healthcare.

If Everspring can replicate Medipay across Sweden, Denmark, and Finland, each with their own healthcare payment complexities, it becomes one of the few Nordic fintech companies with genuine cross-border operational depth in a vertical that's recession-resistant by nature. People don't stop needing healthcare when the economy dips.

This deal fits a pattern that's accelerating across European fintech. Banks built or acquired technology platforms during the digital transformation wave. Many of those platforms grew into substantial businesses but remained trapped inside banking structures that limited their strategic flexibility.

Private equity firms have noticed. The thesis is straightforward: take a proven platform with existing revenue, separate it from the parent's constraints, install experienced leadership from the payments industry (hence the Visa hire), and scale it independently. Erik Bork, CEO of Mimir, described it as "exactly the type of platform we look to build and scale" with "proven technology, real commercial traction, and a clear path to expansion."

The retained minority stake from PayEx is deliberate. It keeps Swedbank connected to the ecosystem, provides Everspring with continued access to banking infrastructure and regulatory relationships, and gives PayEx upside if the independence thesis works. It's alignment without control.

Nelson Walden spent his Visa years building relationships across every major financial institution in the Nordics and Baltics. That network is the first thing Mimir is buying. The second is his understanding of how payments ecosystems actually work at scale, the partnerships, integrations, and regulatory approvals that determine whether a fintech platform grows or stalls.

His priorities are probably already set. Stabilize the transition, make sure no existing customers feel disrupted by the ownership change, then start the expansion conversations that PayEx's corporate structure made difficult. Sweden is the obvious first target after Norway. The healthcare vertical via Medipay is the highest-value growth path.

The risk? Carve-outs sometimes lose the institutional relationships that made them valuable in the first place. Everspring's customers chose PayEx partly because it was backed by Swedbank. If those customers get nervous about the new ownership structure, the transition period gets bumpy.

Mimir knows this. The "no disruption" guarantee for existing clients isn't just customer service. It's the foundation of the entire investment thesis.